Method for separating kidney immune cells
By combining enzymatic digestion with room temperature sedimentation and density gradient separation, the problem of low separation efficiency and antigen damage of mouse kidney immune cells in existing technologies has been solved, achieving the separation of high-purity and high-activity immune cells, which is applicable to a variety of mouse models and disease models.
Patent Information
- Application Number
- CN202610273377.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-06
- Publication Date
- 2026-05-19
AI Technical Summary
Existing technologies struggle to efficiently separate immune cells, especially rare immune cell subsets, from mouse kidneys. Furthermore, prolonged enzymatic digestion can damage cell surface antigens and increase impurities, affecting subsequent detection and analysis.
A method combining enzymatic digestion with room temperature sedimentation and density gradient separation was used to separate high-purity, high-viability immune cells by digesting kidney tissue with collagenase IV and DNAase I at 37°C for 40 minutes, followed by standing at room temperature and centrifugation using Percoll density gradient.
It significantly improves cell yield and viability, reduces interference from impurities, and preserves the integrity of immune cell surface antigens to the maximum extent, making it suitable for demanding experiments such as flow cytometry and single-cell sequencing.
Smart Images

Figure CN122060672A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of cell separation technology, specifically relating to a method for separating kidney immune cells. Background Technology
[0002] As a vital metabolic and immune organ, the kidney's immune microenvironment is crucial for understanding the pathogenesis of kidney diseases such as acute kidney injury, chronic kidney disease, and lupus nephritis. Mouse models are the primary tool for renal immunology research; therefore, the efficient and high-purity isolation of immune cells (such as T cells, B cells, macrophages, dendritic cells, and neutrophils) from mouse kidneys is a key prerequisite for subsequent flow cytometry, single-cell sequencing, and in vitro functional experiments.
[0003] Currently, conventional methods for isolating mouse kidney immune cells mainly rely on mechanical fragmentation combined with enzymatic digestion (such as collagenase IV and DNase I). However, this method has significant drawbacks: First, kidney tissue is dense, and conventional digestion procedures (usually 37°C, 30-45 minutes) are insufficient to fully dissociate the tissue, resulting in low cell yield, especially for certain rare immune cell subsets; second, the prolonged enzymatic digestion process can damage cell surface antigens, particularly certain sensitive chemokine receptors or activation markers, affecting the accuracy of subsequent flow cytometry detection; third, the cell suspension after digestion often contains a large number of renal parenchymal cell fragments and dead cells, severely interfering with the purification and analysis of target immune cells. Summary of the Invention
[0004] The purpose of this invention is to provide a method for isolating kidney immune cells, which can achieve mouse kidney immune cells that can ensure high cell viability and yield, effectively remove impurities, and retain the integrity of immune cell surface antigens to the maximum extent, thereby solving the problems existing in the above-mentioned background art.
[0005] To achieve the above objectives, this application employs the following technical solution:
[0006] A method for isolating kidney immune cells includes the following steps:
[0007] S1. Obtain mouse kidney tissue blocks;
[0008] S2. Place the kidney tissue block from step S1 in RPMI 1640 medium containing 2 mg / ml collagenase IV, 500 ng / ml DNAase I and 10% fetal bovine serum, and digest with shaking at 37°C for 40 minutes.
[0009] After S3 and 40 min, the reaction was terminated by adding culture medium containing 10% FBS.
[0010] S4. Let stand at room temperature for 5 minutes and collect the upper single-cell suspension;
[0011] S5. Add 5ml of PBS to wash the cells, centrifuge at 1700rpm, 10 / 10, at room temperature for 5min, discard the supernatant, and repeat the washing once.
[0012] S6. Using the discontinuous Percoll density gradient centrifugation method, centrifuge at 2000 rpm for 25 minutes at 25℃ without brakes.
[0013] S7. Collect cells with 40%-80% of the high interfacial layer and wash with PBS;
[0014] S8. Resuspend the washed cells in a suitable buffer solution to obtain mouse kidney immune cells.
[0015] Furthermore, in step S1, the step of obtaining mouse kidney tissue blocks is as follows:
[0016] S11. Remove the mouse kidneys under sterile conditions and place them on ice;
[0017] S12. Remove the renal capsule and cut the renal tissue into 1 mm³ tissue blocks.
[0018] Furthermore, in step S2, each kidney tissue block requires 5 ml of RPMI 1640 medium containing 2 mg / ml collagenase IV and 500 ng / ml DNAase I in 10% fetal bovine serum for digestion.
[0019] Furthermore, in step S2, the tissue is checked every 10 minutes, and any lumps are immediately shaken to mix.
[0020] Furthermore, in step S6, a discontinuous Percoll density gradient centrifugation method is used. Specifically, the cells are first resuspended in 1 ml of 40% Percoll solution, transferred to a flow cytometry tube, and then 80% Percoll solution is injected into the lower layer.
[0021] Furthermore, in step S8, the buffer solution is PBS containing 2% fetal bovine serum.
[0022] The beneficial effects of this invention are:
[0023] This technical solution significantly improves cell yield and viability: through a three-step optimized scheme of "enzymatic digestion + room temperature sedimentation + density gradient separation", cell damage is greatly reduced while gently dissociating tissue.
[0024] Maximum protection of cell surface antigens: effectively reduces antigen loss or degradation caused by enzyme activity and metabolism.
[0025] Highly efficient and thorough impurity removal: The unique "enzyme digestion + room temperature sedimentation + density gradient separation" process is specifically designed to address the challenges of high levels of impurities and fragments in kidney cell suspensions.
[0026] The method is stable and widely applicable: This protocol is applicable to kidney tissues of common mouse strains such as C57BL / 6 and BALB / c, as well as normal mice and disease models (such as ischemia-reperfusion injury and diabetic nephropathy) mice, and has good reproducibility. Attached Figure Description
[0027] Figure 1 This is a single-cell suspension of isolated kidney immune cells;
[0028] Figure 2 The percentage of CD45+ immune cells in a single-cell suspension of isolated kidney immune cells. Detailed Implementation
[0029] The technical solution of the present invention will be described in detail below with reference to the accompanying drawings. The following embodiments are merely exemplary and can only be used to explain and illustrate the technical solution of the present invention, and should not be construed as limiting the technical solution of the present invention.
[0030] This technical solution proposes a method for isolating mouse kidney immune cells that can ensure high cell viability and yield while effectively removing impurities and preserving the integrity of immune cell surface antigens to the maximum extent.
[0031] This method, through an optimized enzyme digestion system, a newly introduced cell sedimentation method, and a unique gradient impurity removal strategy, achieves higher yield, higher viability, and higher purity of mouse kidney immune cells in a shorter time, while maximizing the protection of the integrity of cell surface antigens.
[0032] like Figure 1 and Figure 2 As shown, this application provides a method for isolating kidney immune cells, comprising the following steps:
[0033] S1. Tissue Acquisition and Preprocessing: The specific steps are as follows:
[0034] S11. Remove the mouse kidneys under sterile conditions and place them on ice;
[0035] S12. Remove the renal capsule and cut the renal tissue into 1 mm³ tissue blocks.
[0036] S2. Optimized Enzyme Digestion: The kidney tissue blocks from step S1 were placed in RPMI 1640 medium containing 2 mg / ml collagenase IV and 500 ng / ml DNAase I in 10% fetal bovine serum. The mixture was incubated at 37°C with shaking for 40 minutes. The tissue was checked every 10 minutes, and any clumps were immediately agitated. In this application, each kidney tissue block required 5 ml of RPMI 1640 medium containing 2 mg / ml collagenase IV and 500 ng / ml DNAase I in 10% fetal bovine serum.
[0037] After S3 and 40 min, the reaction was terminated by adding culture medium containing 10% FBS.
[0038] S4. Let stand at room temperature for 5 minutes and collect the upper single-cell suspension.
[0039] S5. Add 5ml of PBS to wash the cells, centrifuge at 1700rpm, 10 / 10, at room temperature for 5min, discard the supernatant, and repeat the washing once to completely discard the supernatant.
[0040] S6. The discontinuous Percoll density gradient centrifugation method was used, specifically: the cells were first resuspended in 1 ml of 40% Percoll solution and transferred to a flow cytometer; then 80% Percoll solution was injected into the lower layer.
[0041] Centrifuge at 2000 rpm for 25 minutes at 25°C without brakes. This step can effectively enrich target immune cells such as lymphocytes and monocytes at the 40% / 80% interface, while most renal tubular epithelial cells, fibroblasts and other parenchymal cells, as well as cell debris and red blood cells, will precipitate at the bottom of the tubule or remain in the upper layer.
[0042] S7. Final passivation: Carefully aspirate cells with 40%-80% of the high interface layer and wash with PBS.
[0043] S8. Resuspend the washed cells in a suitable PBS buffer containing 2% FBS to obtain high-purity, high-viability mouse kidney immune cells, suitable for flow cytometry, cell sorting, and in vitro culture.
[0044] This technique significantly improves cell yield and viability: through a three-step optimized process of "enzymatic digestion + room temperature sedimentation + density gradient separation," cell damage is greatly reduced while gently dissociating tissue. Experiments show that compared with the traditional single collagenase IV digestion method, this method increases the total yield of CD45+ immune cells by an average of more than 40%, and the cell viability (trypan blue method) remains above 95%.
[0045] Maximum protection of cell surface antigens: Effectively reduces antigen loss or degradation caused by enzyme activity and metabolism. Flow cytometry analysis confirms that immune cells isolated by this method have higher mean fluorescence intensity (MFI) of key surface markers (such as CD3, CD19, CD11c, and F4 / 80), lower background staining, and more accurate detection results.
[0046] Highly efficient and thorough impurity removal: The unique "enzyme digestion + room temperature sedimentation + density gradient separation" process is specifically designed to address the challenges of high levels of impurities and debris in kidney cell suspensions. This process removes over 90% of non-target CD45- cells and cell debris, significantly "purifying" the final cell products, reducing interference in subsequent experiments, and improving the accuracy of flow cytometry sorting and data analysis.
[0047] The method is stable and highly versatile: This protocol is applicable to kidney tissue from common mouse strains such as C57BL / 6 and BALB / c, as well as normal mice and disease models (such as ischemia-reperfusion injury and diabetic nephropathy) mice, with good reproducibility. The isolated cells can be directly used for cutting-edge technologies with extremely high cell quality requirements, such as single-cell RNA sequencing (scRNA-seq).
[0048] The above are preferred embodiments of the present invention. The basic principles and advantages of the present invention have been shown and described above. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The embodiments and descriptions in the specification are only illustrative of the principles of the present invention. Various changes and modifications can be made to the present invention without departing from the spirit and scope of the present invention. All such changes and modifications fall within the scope of the present invention as claimed. The scope of protection of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for isolating renal immune cells, characterized in that, Includes the following steps: S1. Obtain mouse kidney tissue blocks; S2. Place the kidney tissue block from step S1 in RPMI 1640 medium containing 2 mg / ml collagenase IV, 500 ng / ml DNAase I and 10% fetal bovine serum, and digest with shaking at 37°C for 40 minutes. After S3 and 40 min, the reaction was terminated by adding culture medium containing 10% FBS. S4. Let stand at room temperature for 5 minutes and collect the upper single-cell suspension; S5. Add 5ml of PBS to wash the cells, centrifuge at 1700rpm, 10 / 10, at room temperature for 5min, discard the supernatant, and repeat the washing once. S6. Using the discontinuous Percoll density gradient centrifugation method, centrifuge at 2000 rpm for 25 minutes at 25℃ without brakes. S7. Collect cells with 40%-80% of the high interfacial layer and wash with PBS; S8. Resuspend the washed cells in a suitable buffer solution to obtain mouse kidney immune cells.
2. The method for isolating renal immune cells according to claim 1, characterized in that, In step S1, the step of obtaining mouse kidney tissue blocks is as follows: S11. Remove the mouse kidneys under sterile conditions and place them on ice; S12. Remove the renal capsule and cut the renal tissue into 1 mm³ tissue blocks.
3. The method for isolating renal immune cells according to claim 1, characterized in that, In step S2, each kidney tissue block requires 5 ml of RPMI 1640 medium containing 2 mg / ml collagenase IV and 500 ng / ml DNAase I in 10% fetal bovine serum for digestion.
4. The method for isolating renal immune cells according to claim 3, characterized in that, In step S2, check the tissue every 10 minutes, and shake it to mix immediately if there are lumps.
5. The method for isolating renal immune cells according to claim 1, characterized in that, In step S6, discontinuous Percoll density gradient centrifugation is used. Specifically, the cells are first resuspended in 1 ml of 40% Percoll solution, transferred to a flow cytometry tube, and then 80% Percoll solution is injected into the lower layer.
6. The method for isolating renal immune cells according to claim 1, characterized in that, In step S8, the buffer solution is PBS containing 2% fetal bovine serum.
